Feng W, Dean DC, Hornicek FJ, Shi H, Duan Z. Exosomes promote pre-metastatic niche formation in ovarian cancer. Mol Cancer. 2019;18:1–11.

Article  CAS  Google Scholar 

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. Ca Cancer J Clin. 2021;71(1):7–33.

PubMed  Google Scholar 

Oswald AJ, Gourley C. Low-grade epithelial ovarian cancer: a number of distinct clinical entities? Curr Opin Oncol. 2015;27(5):412–9.

Article  CAS  PubMed  Google Scholar 

Groen RS, Gershenson DM, Fader AN. Updates and emerging therapies for rare epithelial ovarian cancers: one size no longer fits all. Gynecol Oncol. 2015;136(2):373–83.

Article  PubMed  Google Scholar 

Helm CW, States JC. Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role. J Ovarian Res. 2009;2:2.

Article  PubMed  PubMed Central  Google Scholar 

Bast RC Jr, Hennessy B, Mills GB. The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer. 2009;9(6):415–28.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Alatise KL, Gardner S, Alexander-Bryant A. Mechanisms of drug resistance in ovarian cancer and associated gene targets. Cancers. 2022;14(24):6246.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Turecek R, Schwenk J, Fritzius T, Ivankova K, Zolles G, Adelfinger L, et al. Auxiliary GABAB receptor subunits uncouple G protein βγ subunits from effector channels to induce desensitization. Neuron. 2014;82(5):1032–44.

Article  CAS  PubMed  Google Scholar 

Booker SA, Althof D, Gross A, Loreth D, Müller J, Unger A, et al. KCTD12 auxiliary proteins modulate kinetics of GABAB receptor-mediated Inhibition in cholecystokinin-containing interneurons. Cereb Cortex. 2017;27(3):2318–34.

PubMed  Google Scholar 

Angrisani A, Di Fiore A, De Smaele E, Moretti M. The emerging role of the KCTD proteins in cancer. Cell Communication Signal. 2021;19(1):56.

Article  CAS  Google Scholar 

Ye RY, Kuang XY, Zeng HJ, Shao N, Lin Y, Wang SM. KCTD12 promotes G1/S transition of breast cancer cell through activating the AKT/FOXO1 signaling. J Clin Lab Anal. 2020;34(8):e23315.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abbaszadegan MR, Taghehchian N, Li L, Aarabi A, Moghbeli M. Contribution of KCTD12 to esophageal squamous cell carcinoma. BMC Cancer. 2018;18(1):853.

Article  PubMed  PubMed Central  Google Scholar 

Kang HJ, Koh KH, Yang E, You KT, Kim HJ, Paik YK, et al. Differentially expressed proteins in Gastrointestinal stromal tumors with KIT and PDGFRA mutations. Proteomics. 2006;6(4):1151–7.

Article  CAS  PubMed  Google Scholar 

Davidson B, Trope CG, Reich R. Epithelial–mesenchymal transition in ovarian carcinoma. Front Oncol. 2012;2:21912.

Article  Google Scholar 

Zhang J, Tian X-J, Xing J. Signal transduction pathways of EMT induced by TGF-β, SHH, and WNT and their crosstalks. J Clin Med. 2016;5(4):41.

Article  PubMed  PubMed Central  Google Scholar 

Moghbeli M, Forghanifard MM, Aarabi A, Mansourian A, Abbaszadegan MR. Clinicopathological sex- related relevance of musashi1 mRNA expression in esophageal squamous cell carcinoma patients. Pathol Oncol Res. 2014;20(2):427–33.

Article  CAS  PubMed  Google Scholar 

Taleb S, Abbaszadegan MR, Moghbeli M, Roudbari NH, Forghanifard MM. HES1 as an independent prognostic marker in esophageal squamous cell carcinoma. J Gastrointest Cancer. 2014;45(4):466–71.

Article  CAS  PubMed  Google Scholar 

Moghbeli M. MicroRNAs as the critical regulators of cisplatin resistance in ovarian cancer cells. J Ovarian Res. 2021;14(1):127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rees DC, Johnson E, Lewinson O. ABC transporters: the power to change. Nat Rev Mol Cell Biol. 2009;10(3):218–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maharati A, Moghbeli M. PI3K/AKT signaling pathway as a critical regulator of epithelial-mesenchymal transition in colorectal tumor cells. Cell Commun Signal. 2023;21(1):201.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abbaszadegan MR, Riahi A, Forghanifard MM, Moghbeli M. WNT and NOTCH signaling pathways as activators for epidermal growth factor receptor in esophageal squamous cell carcinoma. Cell Mol Biol Lett. 2018;23:42.

Article  PubMed  PubMed Central  Google Scholar 

Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, Ahmad S, et al. Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med. 2019;8(16):7018–31.

Article  PubMed  PubMed Central  Google Scholar 

Stewart C, Ralyea C, Lockwood S. Ovarian cancer: an integrated review. Semin Oncol Nurs. 2019;35(2):151–6.

Article  PubMed  Google Scholar 

Alatise KL, Gardner S, Alexander-Bryant A. Mechanisms of drug resistance in ovarian cancer and associated gene targets. Cancers (Basel). 2022;14(24):6246.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brasseur K, Gévry N, Asselin E. Chemoresistance and targeted therapies in ovarian and endometrial cancers. Oncotarget. 2017;8(3):4008–42.

Article  PubMed  PubMed Central  Google Scholar 

Angrisani A, Di Fiore A, De Smaele E, Moretti M. The emerging role of the KCTD proteins in cancer. Cell Commun Signal. 2021;19(1):56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li L, Duan T, Wang X, Zhang RH, Zhang M, Wang S, et al. KCTD12 regulates colorectal cancer cell stemness through the ERK pathway. Sci Rep. 2016;6:20460.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen W, Li Y, Li B, Zheng L, Xie X, Le J, et al. Downregulation of KCTD12 contributes to melanoma stemness by modulating CD271. Cancer Biol Med. 2019;16(3):498–513.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Z, Wu D, Dong M, Xia Y, Xu T. KCTD12 is a prognostic marker of breast cancer and correlates with tumor immune cell infiltration. Transl Cancer Res. 2021;10(1):261–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, Xu WW, Hong P, Ye F, Huang XH, Hu HF, et al. Adefovir dipivoxil sensitizes colon cancer cells to Vemurafenib by disrupting the KCTD12-CDK1 interaction. Cancer Lett. 2019;451:79–91.

Article  CAS  PubMed  Google Scholar 

Engqvist H, Parris TZ, Kovács A, Rönnerman EW, Sundfeldt K, Karlsson P, et al. Validation of novel prognostic biomarkers for Early-Stage Clear-Cell, endometrioid and mucinous ovarian carcinomas using immunohistochemistry. Front Oncol. 2020;10:162.

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Li HR, Yu JJ, Li FX. Induction of tumor suppressor KCTD11 during periovulatory period in rat ovary. Reprod Biol. 2019;19(2):173–8.